Chris Carey

Stock Analyst at Wells Fargo

(3.47)
# 930
Out of 5,138 analysts
453
Total ratings
53.02%
Success rate
3.26%
Average return

Stocks Rated by Chris Carey

Colgate-Palmolive Company
Jan 13, 2026
Upgrades: Equal-Weight
Price Target: $77$86
Current: $85.44
Upside: +0.66%
Constellation Brands
Jan 8, 2026
Maintains: Overweight
Price Target: $160$165
Current: $163.64
Upside: +0.83%
The Procter & Gamble Company
Jan 5, 2026
Maintains: Overweight
Price Target: $170$158
Current: $147.00
Upside: +7.48%
The Clorox Company
Jan 5, 2026
Maintains: Equal-Weight
Price Target: $117$108
Current: $109.84
Upside: -1.68%
Kimberly-Clark
Jan 5, 2026
Maintains: Equal-Weight
Price Target: $110$105
Current: $101.48
Upside: +3.47%
Edgewell Personal Care Company
Jan 5, 2026
Maintains: Overweight
Price Target: $23$20
Current: $19.29
Upside: +3.68%
Church & Dwight Co.
Jan 5, 2026
Maintains: Overweight
Price Target: $100$92
Current: $92.15
Upside: -0.16%
Mondelez International
Jan 5, 2026
Maintains: Overweight
Price Target: $72$62
Current: $57.99
Upside: +6.91%
General Mills
Jan 5, 2026
Maintains: Equal-Weight
Price Target: $51$49
Current: $44.45
Upside: +10.24%
Conagra Brands
Jan 5, 2026
Maintains: Equal-Weight
Price Target: $19$18
Current: $17.17
Upside: +4.83%
Maintains: Overweight
Price Target: $50$63
Current: $53.93
Upside: +16.82%
Maintains: Overweight
Price Target: $83$86
Current: $81.47
Upside: +5.56%
Upgrades: Equal-Weight
Price Target: $157$182
Current: $198.87
Upside: -8.48%
Maintains: Equal-Weight
Price Target: $31$30
Current: $26.46
Upside: +13.38%
Downgrades: Equal-Weight
Price Target: $53$50
Current: $50.00
Upside: -
Downgrades: Equal-Weight
Price Target: $53$50
Current: $50.95
Upside: -1.86%
Maintains: Equal-Weight
Price Target: $55$62
Current: $62.45
Upside: -0.72%
Maintains: Equal-Weight
Price Target: $27$25
Current: $23.76
Upside: +5.22%
Maintains: Overweight
Price Target: $33$35
Current: $27.95
Upside: +25.22%
Maintains: Overweight
Price Target: $75$79
Current: $71.75
Upside: +10.10%
Maintains: Equal-Weight
Price Target: $150$154
Current: $147.66
Upside: +4.29%
Maintains: Overweight
Price Target: $75$67
Current: $62.80
Upside: +6.69%
Maintains: Equal-Weight
Price Target: $5$4
Current: $3.14
Upside: +27.39%
Maintains: Overweight
Price Target: $115$120
Current: $103.20
Upside: +16.28%
Maintains: Equal-Weight
Price Target: $5$6
Current: $4.22
Upside: +42.18%
Maintains: Equal-Weight
Price Target: $1.25$1
Current: $1.88
Upside: -46.81%
Maintains: Overweight
Price Target: $275$290
Current: $114.46
Upside: +153.36%
Maintains: Equal-Weight
Price Target: $20$15
Current: $1.55
Upside: +867.74%
Maintains: Equal-Weight
Price Target: $3.5$4
Current: $1.44
Upside: +177.78%
Maintains: Neutral
Price Target: $128$110
Current: $79.85
Upside: +37.76%
Initiates: Underweight
Price Target: $80
Current: $1.15
Upside: +6,856.52%
Upgrades: Buy
Price Target: $25$26
Current: $31.80
Upside: -16.98%
Upgrades: Buy
Price Target: $25$26
Current: $28.88
Upside: -8.59%
Reiterates: Neutral
Price Target: $2,200$2,000
Current: $8.75
Upside: +22,757.14%
Initiates: Underperform
Price Target: $87
Current: $19.11
Upside: +355.26%